682: Synergistic combination of valproic acid and oncolytic parvovirus H-1PV as a potential therapy against cervical and pancreatic carcinomas
Jinlong Li(Southwest Petroleum University), Antonio Marchini(European Commission)
Cited by 7
Related Papers
Immune Conversion of Tumor Microenvironment by Oncolytic Viruses: The Protoparvovirus H-1PV Case Study
|Frontiers in Immunology|2019|87